Trials / Recruiting
RecruitingNCT06341270
Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy
Efficacy of Transcutaneous Electrical Acupoint Stimulation on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy:a Prospective, Randomized Controlled Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 524 (estimated)
- Sponsor
- West China Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to access the effect of transcutaneous electrical acupoint stimulation on postoperative pain in patients undergoing hepatectomy
Detailed description
Patients who meet the enrollment criteria will be randomized 1:1 to either the transcutaneous electrical acupoint stimulation (TEAS#or the sham groups. In the TEAS group, the acupoints are bilateral neiguan (PC6) , Hegu(L14), Yanglingquan(GB34), Zusanli(ST 36) and Renying(ST9) acupoints. Patients will receive TEAS 30min before anesthesia until being discharged from the post-anaesthesia care unit (PACU). The same treatment for 30 min will be performed on the 1st, 2nd and 3rd days after surgery.The stimulation intensity will be adjusted in accordance with the maximal level tolerated by each patient. Patients in the sham group will receive electrode attachment but without stimulation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | transcutaneous electrical acupoint stimulation | transcutaneous electrical acupoint stimulation Transcutaneous electrical acupoint stimulation (TEAS) is a contemporary modification of traditional acupuncture that sends electrical impulses into acupoints through electrodes on the skin surface. In the TEAS group, patients will receive TEAS 30min before anesthesia until be discharged from the postanaesthesia care unit (PACU). The same treatment will be performed on the 1st, 2nd and 3rd days after surgery.The stimulation intensity will be adjusted in accordance with the maximal level tolerated by each patient. |
| DEVICE | sham transcutaneous electrical acupoint stimulation | Patients in the sham group will receive electrode attachment but without stimulation. |
Timeline
- Start date
- 2024-05-06
- Primary completion
- 2026-04-20
- Completion
- 2026-12-20
- First posted
- 2024-04-02
- Last updated
- 2024-07-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06341270. Inclusion in this directory is not an endorsement.